Don’t miss the opportunity to see Linda Persson summarise 2023, an eventful year in which several significant milestones were achieved.
“In summary, we have delivered as planned and strengthened our position as a company. We look forward to continuing our efforts to improve diagnostics for rectal cancer patients. Many thanks to my colleagues and to all of NanoEcho’s investors for your support and confidence. We look forward to an equally successful 2024,” says Linda Persson.
You can find out more about 2023 in the Annual Report communication that has been published today: https://storage.mfn.se/65627ed6-dcd1-4a2c-8499-630e66a78f4a/nanoecho-ab-bokslutskommunike-2023.pdf
